Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Heritable Pulmonary Arterial Hypertension

fluorodeoxyglucose f18 has been researched along with Heritable Pulmonary Arterial Hypertension in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (85.71)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Fang, W; Gu, Y; Han, K; Wang, L; Yan, C; Zhang, Z; Zhao, Z1
Asosingh, K; Comhair, SA; Davis, L; DiFilippo, FP; Dostanic, I; Erzurum, SC; Graham, BB; Lundgrin, EL; Neumann, DR; Park, MM; Sharp, J; Tang, WH; Thomas, JD; Tuder, RM1
Aboagye, EO; Ashek, A; Barnes, G; Cotroneo, E; Cupitt, J; Dabral, S; Dubois, O; El-Bahrawy, MA; Fang, W; Gibbs, JS; Gsell, W; He, JG; Howard, LS; Jones, H; Nguyen, QD; Pullamsetti, SS; Tomasi, G; Wang, L; Wilkins, MR; Zhao, L1
Cai, Q; Fang, W; He, J; Li, W; Ma, X; Wang, L; Wu, W; Xiong, C; Yang, Y1
Can, MM; Canpolat, N; Kaymaz, C; Ozdemir, N; Sonmez, K; Tanboga, IH; Tokgoz, HC; Turkyilmaz, E1
Barst, RJ; Bokhari, J; Bokhari, S; Einstein, AJ; Johnson, LL; Raina, A; Rosenweig, EB; Schulze, PC1
Archer, SL; Bache-Wiig, P; Chen, CT; Haney, CR; Marsboom, G; Morrow, E; Paul, J; Piao, L; Ryan, JJ; Thenappan, T; Toth, PT; Wietholt, C1

Trials

1 trial(s) available for fluorodeoxyglucose f18 and Heritable Pulmonary Arterial Hypertension

ArticleYear
Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatments.
    Circulation, 2013, Sep-10, Volume: 128, Issue:11

    Topics: Adult; Aged; Animals; Benzamides; Cell Division; Dichloroacetic Acid; Disease Models, Animal; Drug Monitoring; Familial Primary Pulmonary Hypertension; Female; Fibroblasts; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gene Expression Profiling; Glycolysis; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Indoles; Lung; Male; Middle Aged; Monocrotaline; Piperazines; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Sunitinib; Young Adult

2013

Other Studies

6 other study(ies) available for fluorodeoxyglucose f18 and Heritable Pulmonary Arterial Hypertension

ArticleYear
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2023, Volume: 30, Issue:2

    Topics: Familial Primary Pulmonary Hypertension; Fibroblasts; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Pilot Projects; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Pulmonary Arterial Hypertension

2023
Fasting 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography to detect metabolic changes in pulmonary arterial hypertension hearts over 1 year.
    Annals of the American Thoracic Society, 2013, Volume: 10, Issue:1

    Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Antigens, CD; Cell Hypoxia; Echocardiography; Erythropoietin; Familial Primary Pulmonary Hypertension; Female; Fluorodeoxyglucose F18; Glucose; Heart Ventricles; Humans; Hypertension, Pulmonary; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Middle Aged; Monitoring, Physiologic; Neovascularization, Pathologic; Positron-Emission Tomography; Reproducibility of Results; Ventricular Dysfunction, Right

2013
Quantitative assessment of right ventricular glucose metabolism in idiopathic pulmonary arterial hypertension patients: a longitudinal study.
    European heart journal. Cardiovascular Imaging, 2016, Volume: 17, Issue:10

    Topics: Adult; Case-Control Studies; Echocardiography; Evaluation Studies as Topic; Exercise Tolerance; Familial Primary Pulmonary Hypertension; Female; Fluorodeoxyglucose F18; Glucose; Hemodynamics; Humans; Longitudinal Studies; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Reference Values; Risk Assessment; Treatment Outcome; Ventricular Function, Right

2016
Increased right ventricular glucose metabolism in patients with pulmonary arterial hypertension.
    Clinical nuclear medicine, 2011, Volume: 36, Issue:9

    Topics: Adult; Blood Pressure; Familial Primary Pulmonary Hypertension; Female; Fluorodeoxyglucose F18; Glucose; Heart Ventricles; Humans; Hypertension, Pulmonary; Male; Middle Aged; Radionuclide Imaging; Ultrasonography

2011
PET imaging may provide a novel biomarker and understanding of right ventricular dysfunction in patients with idiopathic pulmonary arterial hypertension.
    Circulation. Cardiovascular imaging, 2011, Volume: 4, Issue:6

    Topics: Adolescent; Adult; Biomarkers; Cohort Studies; Contrast Media; Diagnostic Imaging; Disease Progression; Echocardiography, Doppler, Color; Electrocardiography; Familial Primary Pulmonary Hypertension; Female; Fluorodeoxyglucose F18; Humans; Hypertension, Pulmonary; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; Sensitivity and Specificity; Severity of Illness Index; Survival Rate; Ventricular Dysfunction, Right; Young Adult

2011
Lung ¹⁸F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertension.
    American journal of respiratory and critical care medicine, 2012, Mar-15, Volume: 185, Issue:6

    Topics: Animals; Disease Models, Animal; Disease Progression; Familial Primary Pulmonary Hypertension; Fluorodeoxyglucose F18; Hypertension, Pulmonary; Monitoring, Physiologic; Oxygen Consumption; Positron-Emission Tomography; Pulmonary Wedge Pressure; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Reproducibility of Results

2012